In addition, alternative splicing expression profile was also successfully used in several studies aiming to discriminate subtypes of breast tumors [71-73], and specific gene expression profiles have also been identified for BRCA1, BRCA2 and CHEK2-associated breast tumors [62, 74]. This evidence concerns the gene BRCA2 and breast neoplasm.